Genes play a significant role in regulating neurotransmitters, which are chemical messengers that transmit signals between nerve cells in the brain. Several neurotransmitters are associated with feelings of happiness, including serotonin, dopamine, and endorphins. Gene variations can affect the production, function, and regulation of these neurotransmitters, which in turn can influence mood and emotional well-being. While genetic factors are important, environmental and lifestyle factors also play a significant role in the complex interplay between genes, neurotransmitters, and happiness.
The COMT gene codes for the enzyme catechol-O-methyltransferase (COMT), which plays a critical role in the metabolism of certain neurotransmitters, including dopamine, norepinephrine, and epinephrine. COMT helps to break down these neurotransmitters in the brain and body, regulating their levels and preventing them from building up to excessive levels.
Certain variants of the COMT gene have been associated with differences in COMT activity and the metabolism of these neurotransmitters. For example, the Val158Met variant is a common polymorphism of the COMT gene that has been shown to result in decreased COMT activity and slower metabolism of dopamine. This can result in higher dopamine levels in the brain, which has been associated with certain behaviors and personality traits, such as impulsivity and risk-taking.
Other variants of the COMT gene may result in higher or lower activity of the enzyme, which can have effects on the levels of other neurotransmitters, such as norepinephrine and epinephrine. These differences in neurotransmitter levels can impact a wide range of cognitive, emotional, and behavioral processes, including attention, mood, and stress response.
Overall, while variations in the COMT gene are just one of many factors that can influence neurotransmitter levels and brain function, they can help provide insights into individual differences in behavior and mental health. However, it is important to note that the relationship between genes, neurotransmitters, and behavior is complex and multifaceted, and much research is still needed to fully understand the mechanisms and implications of these relationships.
Glutamate is an important neurotransmitter in the central nervous system, and is involved in a wide range of processes, including learning and memory, neural development, and the regulation of various physiological functions. It is the most abundant excitatory neurotransmitter in the brain and works by binding to glutamate receptors on neurons, which in turn activate various signaling pathways.
Imbalances in glutamate levels and activity have been implicated in various neurological and psychiatric disorders, including Alzheimer's disease, schizophrenia, and depression. For example, excessive glutamate release and activation of glutamate receptors can cause neuronal damage and cell death, a process called excitotoxicity, which has been implicated in several neurodegenerative diseases. In contrast, reduced glutamate activity has been linked to depression and other mood disorders.
The balance of glutamate in the brain is tightly regulated, and disturbances in glutamate levels and signaling can have profound effects on brain function and behavior.
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75: 807–821
Harrison PJ, Tunbridge EM. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology. 2008 Dec;33(13):3037-45. doi: 10.1038/sj.npp.1301543. Epub 2007 Sep 5. PMID: 17805313.
Veronika Husarova and Daniela Ostatnikova (2013), "Monosodium Glutamate Toxic Effects and Their Implications for Human Intake: A Review," JMED Research, Vol. 2013 (2013), Article ID 608765, DOI: 10.5171/2013.608765
Peter S. Whitton, Glutamatergic control over brain dopamine release in vivo and in vitro, Neuroscience & Biobehavioral Reviews,Volume 21, Issue 4,1997,Pages 481-488,ISSN 0149-7634,https://doi.org/10.1016/S0149-7634(96)00034-6.
Dfarhud D, Malmir M, Khanahmadi M. Happiness & Health: The Biological Factors- Systematic Review Article. Iran J Public Health. 2014 Nov;43(11):1468-77. PMID: 26060713; PMCID: PMC4449495.
Blum K, Chen ALC, Chen TJH, Bowirrat A, Downs BW, Waite RL, et al. (2009). Genes and Happiness. Gene Ther Mol Biol, 13: 91–129.
Methylation balancing is unique to each person, but can be done through diet and lifestyle changes.